Table 1 Patient characteristics.
All N = 301 | No PreCI nor POCD N = 243 | PreCI N = 34 | POCD N = 25 | |
|---|---|---|---|---|
Age [years]—mean (SD) | 72.4 (4.9) | 72.0 (4.8) | 73.7 (4.4) | 75.1 (6.0) |
Female sex | 131 (43.5%) | 104 (42.8%) | 17 (50%) | 11 (44.0%) |
Body mass index (BMI)—median (IQR) | 26.6 (5.1) | 26.5 (5.0) | 26.8 (7.6) | 27.1 (7.4) |
PreCI | 34 (11.3%) | – | – | 1 (4.0%) |
Postoperative delirium | 44 (14.6%) | 36 (14.8%) | 7 (20.6%) | 1 (4.0%) |
POCD | 25 (8.3%) | – | 1 (2.9%) | – |
Diabetes | 72 (23.9%) | 59 (24.3%) | 7 (20.6%) | 6 (24.0%) |
Hypertension | 203 (67.4%) | 163 (67.1%) | 22 (64.7%) | 18 (72.0%) |
History of stroke | 13 (4.3%) | 9 (3.7%) | 3 (8.3%) | 1 (4.0%) |
Malignancy | 115 (38.2%) | 96 (39.5%) | 12 (35.3%) | 7 (28.0%) |
Preoperative anaemia | 81 (26.9%) | 65 (26.7%) | 9 (26.5%) | 8 (23.0%) |
Mini-mental state examination (MMSE)—median (IQR) | 29 (2.0) | 29 (2) | 28 (2) | 28 (1.1) |
Benzodiazepine premedication | 38 (12.6%) | 29 (11.9%) | 4 (11.8%) | 5 (20.0%) |
Duration of anesthesia [min]—mean (SD) | 183.9 (116.3) N = 295 | 194.5 (120.7) N = 238 | 137.8 (88.8) N = 33 | 142.4 (74.6) |
Type of anesthesia | ||||
General | 230 (76.4%) | 178 (73.3%) | 31 (91.2%) | 22 (88.0%) |
Regional | 15 (5%) | 13 (5.3%) | 1 (2.9%) | 1 (4.0%) |
Combined | 56 (18.6%) | 52 (21.4%) | 2 (5.9%) | 2 (8.0%) |
Type of surgery | ||||
Musculoskeletal | 85 (28.2%) | 69 (28.4%) | 9 (26.5%) | 8 (32.0%) |
Gastrointestinal | 51 (16.9%) | 45 (18.5%) | 2 (5.9%) | 4 (16.0%) |
Cardiovascular or thoracic | 17 (5.6%) | 15 (6.2%) | 1 (2.9%) | 1 (4.0%) |
Genitourinary | 66 (21.9%) | 54 (22.2%) | 9 (26.5%) | 3 (12.0%) |
Otorhinolaryngology | 23 (7.6%) | 16 (6.6%) | 6 (17.6%) | 1 (4.0%) |
Oral and maxillofacial | 16 (5.3%) | 10 (4.1%) | 5 (14.7%) | 1 (4.0%) |
Ophthalmology | 22 (7.3%) | 18 (7.4%) | 1 (2.9%) | 3 (12.0%) |
Neurosurgery | 6 (2.0%) | 3 (1.2%) | 1 (2.9%) | 2 (8.0%) |
Other | 15 (5.0%) | 13 (5.3%) | 0 (0%) | 2 (8.0%) |
ASA score | ||||
ASA I | 7 (2.3%) | 6 (2.5%) | 1 (2.9%) | 0 (0%) |
ASA II | 204 (67.8%) | 166 (68.3%) | 23 (67.6%) | 16 (64%) |
ASA III | 90 (29.9%) | 71 (29.2%) | 10 (29.4%) | 9 (36%) |
Length of stay [days]—median (IQR) | 6 (6) | 6 (6) | 5.5 (5.25) | 4 (6) |
Inhouse mortality | 5 (1.7%) | 4 (1.6%) | 1 (2.9%) | – |
Follow-up at 3 months | 212 (70.4%) | 168 (69.1%) | 20 (58.8%) | – |
Thalamus volume [cm3]—mean (SD) | 12.9 (1.6) | 13.0 (2.5) | 12.5 (1.3) | 13.1 (1.6) |
Intracranial volume [cm3]—mean (SD) | 1339.0 (212.4) | 1333.4 (207.9) | 1321.6 (216.8) | 1414.7 (239.4) |